A detailed history of Israel Englander (Millennium Management LLC) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Millennium Management LLC holds 2,350,280 shares of RPRX stock, worth $62.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,350,280
Previous 4,667,146 49.64%
Holding current value
$62.6 Million
Previous $142 Million 56.28%
% of portfolio
0.03%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$26.26 - $29.9 $60.8 Million - $69.3 Million
-2,316,866 Reduced 49.64%
2,350,280 $62 Million
Q1 2024

May 15, 2024

BUY
$27.46 - $31.33 $83.8 Million - $95.6 Million
3,052,745 Added 189.09%
4,667,146 $142 Million
Q4 2023

Feb 14, 2024

SELL
$26.21 - $29.22 $6.84 Million - $7.62 Million
-260,826 Reduced 13.91%
1,614,401 $45.3 Million
Q2 2023

Aug 14, 2023

SELL
$29.6 - $36.56 $4.84 Million - $5.98 Million
-163,655 Reduced 8.03%
1,875,227 $57.6 Million
Q1 2023

May 15, 2023

BUY
$32.77 - $39.4 $34.6 Million - $41.5 Million
1,054,516 Added 107.13%
2,038,882 $73.5 Million
Q4 2022

Feb 14, 2023

BUY
$39.17 - $44.04 $36.2 Million - $40.7 Million
923,481 Added 1516.76%
984,366 $38.9 Million
Q3 2022

Nov 14, 2022

SELL
$39.88 - $44.65 $7.51 Million - $8.41 Million
-188,321 Reduced 75.57%
60,885 $2.45 Million
Q2 2022

Aug 15, 2022

BUY
$37.53 - $44.22 $4.16 Million - $4.9 Million
110,837 Added 80.1%
249,206 $10.5 Million
Q1 2022

May 16, 2022

BUY
$37.46 - $42.44 $3.96 Million - $4.48 Million
105,599 Added 322.24%
138,369 $5.39 Million
Q4 2021

Feb 14, 2022

SELL
$35.17 - $42.48 $24.2 Million - $29.2 Million
-688,414 Reduced 95.46%
32,770 $1.31 Million
Q3 2021

Nov 15, 2021

SELL
$36.14 - $42.24 $1.37 Million - $1.61 Million
-38,016 Reduced 5.01%
721,184 $26.1 Million
Q2 2021

Aug 16, 2021

BUY
$39.85 - $46.63 $23.9 Million - $27.9 Million
599,181 Added 374.44%
759,200 $31.1 Million
Q1 2021

May 17, 2021

BUY
$42.34 - $52.82 $6.78 Million - $8.45 Million
160,019 New
160,019 $6.98 Million
Q4 2020

Feb 16, 2021

SELL
$36.12 - $50.05 $1.57 Million - $2.18 Million
-43,557 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$38.56 - $48.36 $26.2 Million - $32.8 Million
-678,245 Reduced 93.97%
43,557 $1.83 Million
Q2 2020

Aug 14, 2020

BUY
$44.5 - $52.11 $32.1 Million - $37.6 Million
721,802 New
721,802 $35 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.